Search Results - "Bugelski, P"

Refine Results
  1. 1

    CNTO 530 : Molecular pharmacology in human UT-7EPO cells and pharmacokinetics and pharmacodynamics in mice by BUGELSKI, P. J, CAPOCASALE, R. J, VOLK, A, NESSPOR, T, JAMES, I. E, HUANG, C, MAKROPOULOS, D, MARSHALL, D, FISHER, P. W, LU, J, ACHUTHANANDAM, R, SPINKA-DOMS, T, KWOK, D, GRADEN, D

    Published in Journal of biotechnology (20-03-2008)
    “…CNTO 530 is a 58 kD antibody Fc domain fusion protein, created using Centocor's MIMETIBODY platform, that contains two EMP1 sequences as a pharmacophore. CNTO…”
    Get full text
    Journal Article
  2. 2

    Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock‐in mice by SNYDER, L. A., RUDNICK, K. A., TAWADROS, R., VOLK, A., TAM, S. H., ANDERSON, G. M., BUGELSKI, P. J., YANG, J.

    Published in Journal of thrombosis and haemostasis (01-02-2008)
    “…Background: Tissue factor (TF) is expressed widely at the subluminal surface of blood vessels and serves as the primary cellular initiator of the extrinsic…”
    Get full text
    Journal Article
  3. 3

    Repeated acetaminophen dosing in rats: adaptation of hepatic antioxidant system by O'Brien, P J, Slaughter, M R, Swain, A, Birmingham, J M, Greenhill, R W, Elcock, F, Bugelski, P J

    Published in Human & experimental toxicology (01-05-2000)
    “…Repeated dosing of acetaminophen (paracetamol) to rats is reported to decrease their sensitivity to its hepatotoxic effects, which are associated with…”
    Get more information
    Journal Article
  4. 4

    Maximization of signal derived from cDNA microarrays by Wildsmith, S E, Archer, G E, Winkley, A J, Lane, P W, Bugelski, P J

    Published in BioTechniques (01-01-2001)
    “…Microarray technology is a powerful tool for generating expression data on a large number of genes simultaneously. However, as for any assay, it must be…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat by Toseland, C. D. N., Campbell, S., Francis, I., Bugelski, P. J., Mehdi, N.

    Published in Diabetes, obesity & metabolism (01-06-2001)
    “…Summary Rosiglitazone (BRL‐49653‐C), a thiazolidinedione, is a potent agonist for the nuclear hormone receptor peroxisome proliferator‐activated receptor gamma…”
    Get full text
    Journal Article
  8. 8

    A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells by LaBranche, C C, Sauter, M M, Haggarty, B S, Vance, P J, Romano, J, Hart, T K, Bugelski, P J, Marsh, M, Hoxie, J A

    Published in Journal of Virology (01-09-1995)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  9. 9

    Binding of Soluble CD4 Proteins to Human Immunodeficiency Virus Type 1 and Infected Cells Induces Release of Envelope Glycoprotein gp120 by Hart, Timothy K., Kirsh, Richard, Ellens, Harma, Sweet, Raymond W., Lambert, Dennis M., Petteway, Stephen R., Leary, Jeffry, Bugelski, Peter J.

    “…Human immunodeficiency virus (HIV) infects cells after binding of the viral envelope glycoprotein gp120 to the cell surface recognition marker CD4. gp120 is…”
    Get full text
    Journal Article
  10. 10

    Evaluation of Alamar Blue Reduction for the In Vitro Assay of Hepatocyte Toxicity by Slaughter, M.R, Bugelski, P.J, O'Brien, P.J

    Published in Toxicology in vitro (01-08-1999)
    “…Alamar Blue (AB) reduction is a promising new in vitro assay which is simple to conduct and amenable to repeated measurements and high-throughput screening;…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Immunomodulatory Effects of Anti-CD4 Antibody in Host Resistance against Infections and Tumors in Human CD4 Transgenic Mice by HERZYK, Danuta J, GORE, Elizabeth R, POLSKY, Rodd, NADWODNY, Kimberly L, MAIER, Curtis C, LIU, Susan, HART, Timothy K, HARMSEN, Allen G, BUGELSKI, Peter J

    Published in Infection and Immunity (01-02-2001)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  12. 12

    Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero by Herzyk, D J, Bugelski, P J, Hart, T K, Wier, P J

    Published in Human & experimental toxicology (01-09-2002)
    “…Keliximab is a human-cynomolgus monkey chimeric (Primatized) monoclonal antibody with specificity for human and chimpanzee CD4. As the preclinical safety…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Evidence of foam cell and cholesterol crystal formation in macrophages incubated with oxidized LDL by fluorescence and electron microscopy by Klinkner, AM, Waites, CR, Kerns, WD, Bugelski, PJ

    “…Macrophage-derived foam cells are a prominent component of developing atherosclerotic lesions. We describe an in vitro model of foam cell formation which…”
    Get full text
    Journal Article
  15. 15

    A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology by BUGELSKI, Peter J, ATIF, Uzma, MOLTON, Sarah, TOEG, Ilana, LORD, Peter G, MORGAN, D. Gwyn

    Published in Pharmaceutical research (01-10-2000)
    “…Recent advances in combinatorial chemistry and high throughput screens for pharmacologic activity have created an increasing demand for in vitro high…”
    Get full text
    Journal Article
  16. 16

    ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats by Rabinovici, R, Bugelski, P J, Esser, K M, Hillegass, L M, Vernick, J, Feuerstein, G

    Published in Journal of applied physiology (1985) (01-04-1993)
    “…We recently reported that the combined administration of lipopolysaccharide (LPS) and platelet-activating factor (PAF) in rats, at doses that are completely…”
    Get more information
    Journal Article
  17. 17

    Differential Gene Expression in Rats Following Subacute Exposure to the Anticonvulsant Sodium Valproate by Plant, N., Barber, P., Horner, E., Cockburn, C.-L., Gibson, G., Bugelski, P., Lord, P.

    Published in Toxicology and applied pharmacology (01-09-2002)
    “…Sodium valproate (VPA) is clinically employed as an anticonvulsant and, to a lesser extent, as a mood stabilizer. While the incidence of toxicity associated…”
    Get full text
    Journal Article
  18. 18

    Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120 by YUNG-KANG FU, HART, T. K, JONAK, Z. L, BUGELSKI, P. J

    Published in Journal of Virology (01-07-1993)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  19. 19

    Chemometric strategies for normalisation of gene expression data obtained from cDNA microarrays by Wu, W., Wildsmith, S.E., Winkley, A.J., Yallop, R., Elcock, F.J., Bugelski, P.J.

    Published in Analytica chimica acta (19-11-2001)
    “…DNA microarray technology is emerging as an important method in Functional Genomics. Microarrays enable rapid, large scale gene expression analysis but the…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Temporal relation between neutrophil accumulation and myocardial reperfusion injury by Smith, 3rd, E F, Egan, J W, Bugelski, P J, Hillegass, L M, Hill, D E, Griswold, D E

    Published in The American journal of physiology (01-11-1988)
    “…Infiltration of polymorphonuclear leukocytes (PMN) is associated with the progression of myocardial infarction and reperfusion injury. However, little is known…”
    Get full text
    Journal Article